Jonathan R. Povilonis

Medtronic and its diabetes business, MiniMed, in connection with MiniMed’s $560 million initial public offering and separation from Medtronic—the second largest medtech IPO in history at the time of offering.

Somnigroup International with respect to securities law matters in its $5 billion acquisition of Mattress Firm Group, and its pending $2.5 billion acquisition of Leggett & Platt.

Cushman & Wakefield PLC on the redomiciliation of its NYSE-listed parent company from the UK to Bermuda.

Blackstone as selling shareholder in the repurchase by Hamilton Insurance Group, Ltd. of the entirety of Blackstone’s minority stake in Hamilton.

The underwriters in SharkNinja’s $313 million SEC-registered secondary follow-on offering.

Viking Global in its PIPE investment in InhibRx.

Section 13 and 16 advice:

• Amundi S.A. with respect to beneficial ownership considerations in its agreement to transfer U.S.-based asset manager Amundi US to Victory Capital Holdings Inc. in exchange for a 26.1% economic stake in the combined company.
• Antofagasta plc in its investment in Compañia de Minas Buenaventura S.A.A. through transactions in the secondary market, including a contingent share purchase transaction with a dealer on June 6, 2023, to acquire beneficial ownership of approximately 19% of the outstanding shares of Buenaventura.
• ENI with respect to U.S. securities law matters in its $70 million minority equity investment in Nouveau Monde Graphite.
• Canyon Partners, one of First Foundation Inc.’s largest stockholders, in the all-stock merger of FirstSun Capital Bancorp (FSUN) and First Foundation (FFWM).